(Q41859761)

13 October 2017

Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L. (English)

1 reference

13 October 2017

0 references

0 references

1 reference

Formukong EA

1

1 reference

PubMed ID

2897447

13 October 2017

Evans AT

series ordinal

2

1 reference

PubMed ID

2897447

13 October 2017

Evans FJ

series ordinal

3

1 reference

13 October 2017

1 February 1988

1 reference

Journal of Pharmacy and Pharmacology

13 October 2017

1 reference

13 October 2017

40

1 reference

13 October 2017

132-134

1 reference

13 October 2017

2

1 reference

Isolation from Cannabis sativa L. of cannflavin--a novel inhibitor of prostaglandin production

13 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB05198.X

Actions of cannabis constituents on enzymes of arachidonate metabolism: anti-inflammatory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB05198.X

The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB05198.X

Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB05198.X

The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1988.TB05198.X

10.1111/J.2042-7158.1988.TB05198.X

21 January 2018

Identifiers

DOI

1 reference

13 October 2017

1 reference

PubMed ID

2897447